Seeking Alpha

Wunderlich bumps PT on Symmetry Medical, sees 6% Implant and Cases growth

  • A PT hike to $11 from $10 at Wunderlich Securities may be helping Symmetry Medical shares (SMA +2.8%) higher.
  • Analyst James Terwilliger, which has a Buy rating on the name, believes 2014 revenue growth will be driven by a 6% boost in the Implant and Cases product lines.
  • On the balance sheet side, Terwilliger postulates that "management will remain focused on reducing debt levels."

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs